Application
Western blot analysis of MTNR1A Antibody (Center) in CEM cell line lysates (35ug/lane). MTNR1A (arrow) was detected using the purified Pab.Application
MTNR1A Antibody (Center) flow cytometric analysis of CEM cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | MTNR1A Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MTNR1A; Melatonin receptor type 1A |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | MTNR1A Melatonin receptor type 1A |
|---|---|
| Molecular Weight(MW) | 39375 Da |
| Function | High affinity receptor for melatonin. Likely to mediates the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity |
| Tissue Specificity | Expressed in hypophyseal pars tuberalis and hypothalamic suprachiasmatic nuclei (SCN). Hippocampus |
| Cellular Localization | Cell membrane; Multi-pass membrane protein. |
| Entrez Gene | 4543 |
|---|
Application
Western blot analysis of MTNR1A Antibody (Center) in CEM cell line lysates (35ug/lane). MTNR1A (arrow) was detected using the purified Pab.
Application
MTNR1A Antibody (Center) flow cytometric analysis of CEM cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
